Search for: "BARNES v. TEXAS" Results 321 - 340 of 373
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
21 Dec 2009, 3:06 am
Miller (Lewis and Clark), Judith V. [read post]
23 Feb 2022, 2:17 pm by Erik J. Heels
Martinez, Alex Verdugo, Xander Bogaerts, Hunter Renfroe, Christian Vázquez, Kike Hernandez, Bobby Dalbec, Christian Arroyo). [read post]
7 Feb 2020, 6:22 am by Robert Chesney
But only if one can put it into practice before the horses are out of the barn,and therein lies a policy (and political) dilemma. [read post]
29 Jan 2010, 7:54 am by Anna Christensen
   ABC News quotes University of Texas law professor Lucas Powe, who speculates that the Justices will likely opt not to attend the State of the Union address next year, while Robert Barnes, writing for the Washington Post, points out that each Justice chooses whether to attend the State of the Union address each year (this year, Justices Stevens, Scalia, and Thomas all skipped the speech). [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]